APA (7th ed.) Citation
(2026). Dual-time-point [F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy. EJNMMI Research.
Chicago Style (17th ed.) Citation
"Dual-time-point [F]FDG-PET/CT as a Prognostic Biomarker in Patients with Pleural Mesothelioma Undergoing Immunotherapy." EJNMMI Research 2026.
MLA (9th ed.) Citation
"Dual-time-point [F]FDG-PET/CT as a Prognostic Biomarker in Patients with Pleural Mesothelioma Undergoing Immunotherapy." EJNMMI Research, 2026.
Warning: These citations may not always be 100% accurate.